We don’t support this browser anymore.
This means our website may not look and work as you would expect. Read more about browsers and how to update them here.

Elevance Health Inc (ELV) Common Stock USD0.01

Sell:$502.48 Buy:$503.53 Change: $0.55 (0.11%)
Prices delayed by at least 15 minutes | Switch to live prices |
Change: $0.55 (0.11%)
Prices delayed by at least 15 minutes | Switch to live prices |
Change: $0.55 (0.11%)
Prices delayed by at least 15 minutes | Switch to live prices |
The selling price currently displayed is higher than the buying price. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of extraordinary price volatility during the trading day.

Business summary

Elevance Health, Inc. is a health company. It operates as a health insurer in the United States. The Company operates through four segments: Health Benefit, CarelonRx, Carelon Services, and Corporate & Other. The Health Benefits segment offers a comprehensive suite of health plans and services to individual, employer group risk-based, employer group fee-based, BlueCard, Medicare, Medicaid and federal employees health benefits (FEHB) program members. The CarelonRx segment includes its pharmacy business. CarelonRx markets and offers pharmacy services to affiliated health plan customers, as well as to external customers outside of the health plans. Carelon Services offers a broad array of healthcare-related services and capabilities to internal and external customers including integrated care delivery, behavioral health, palliative care, utilization management, payment integrity services and subrogation services, as well as health and wellness programs.

Contact details

220 Virginia Avenue
United States
+1 (317) 4886000

Important dates

Future events
There are no future events available.
Past events
There are no past events available.

General stock information

Short code:
Market cap:
$118.06 billion
Shares in issue:
232.67 million
Managed Health Care
New York Stock Exchange
United States
US dollar

Key personnel

  • Gail Boudreaux
    President, Chief Executive Officer, Director
  • Mark Kaye
    Chief Financial Officer, Executive Vice President
  • Peter Haytaian
    Executive Vice President and President, Carelon and CarelonRx
  • Charles Kendrick
    Executive Vice President and President, Commercial and Specialty Business Division
  • Felicia Norwood
    Executive Vice President, President - Government Business Division
  • Blair Todt
    Executive Vice President, Chief Legal Officer
  • Ronald Penczek
    Chief Accounting Officer, Controller

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Business summary, contact details and key personnel provided by Thomson Reuters. Important dates provided by Digital Look Ltd. General stock information provided by Reuters.

The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.

Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.